The promise of induced pluripotent stem cells in research and therapy (original) (raw)

• Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006). This breakthrough paper describes the derivation of iPS cells directly from mouse somatic cells through the ectopic co-expression of reprogramming transcription factors, providing an alternative source of pluripotent cells for research.
  Article CAS PubMed Google Scholar
• Dreisch, H. Entwicklungsmechanische Studien I. Der Wert der ersten beiden Furchungszellen in der Echinodermenentwickelung. Experimentelle Erzeugung von Teil und Doppelbildungen. Z. Wiss. Zool. 53, 160–183 (1891).
  Google Scholar
• Dewey, M. J., Martin, D. W. Jr, Martin, G. R. & Mintz, B. Mosaic mice with teratocarcinoma-derived mutant cells deficient in hypoxanthine phosphoribosyltransferase. Proc. Natl Acad. Sci. USA 74, 5564–5568 (1977).
  ADS CAS PubMed PubMed Central Google Scholar
• Gardner, R. L. Mouse chimeras obtained by the injection of cells into the blastocyst. Nature 220, 596–597 (1968).
  ADS CAS PubMed Google Scholar
• Brinster, R. L. The effect of cells transferred into the mouse blastocyst on subsequent development. J. Exp. Med. 140, 1049–1056 (1974).
  CAS PubMed PubMed Central Google Scholar
• Evans, M. J. & Kaufman, M. H. Establishment in culture of pluripotential cells from mouse embryos. Nature 292, 154–156 (1981).
  ADS CAS PubMed Google Scholar
• Martin, G. R. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl Acad. Sci. USA 78, 7634–7638 (1981).
  ADS CAS PubMed PubMed Central Google Scholar
• Thomson, J. A. et al. Embryonic stem cell lines derived from human blastocysts. Science 282, 1145–1147 (1998).
  ADS CAS PubMed Google Scholar
• Vogel, G. & Holden, C. Ethics questions add to concerns about NIH lines. Science 321, 756–757 (2008).
  CAS PubMed Google Scholar
• Mosher, J. T. et al. Lack of population diversity in commonly used human embryonic stem-cell lines. N. Engl. J. Med. 362, 183–185 (2010).
  CAS PubMed Google Scholar
• Tabar, V. et al. Therapeutic cloning in individual parkinsonian mice. Nature Med. 14, 379–381 (2008).
  CAS PubMed Google Scholar
• Noggle, S. et al. Human oocytes reprogram somatic cells to a pluripotent state. Nature 478, 70–75 (2011).
  ADS CAS PubMed Google Scholar
• Park, I. H. et al. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451, 141–146 (2008).
  ADS CAS PubMed Google Scholar
• Takahashi, K. et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131, 861–872 (2007).
  CAS PubMed Google Scholar
• Yu, J. et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 318, 1917–1920 (2007).
  Article ADS CAS PubMed Google Scholar
• Stadtfeld, M., Brennand, K. & Hochedlinger, K. Reprogramming of pancreatic β cells into induced pluripotent stem cells. Curr. Biol. 18, 890–894 (2008).
  CAS PubMed PubMed Central Google Scholar
• Eminli, S., Utikal, J., Arnold, K., Jaenisch, R. & Hochedlinger, K. Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression. Stem Cells 26, 2467–2474 (2008).
  CAS PubMed Google Scholar
• Kim, J. B. et al. Pluripotent stem cells induced from adult neural stem cells by reprogramming with two factors. Nature 454, 646–650 (2008).
  ADS CAS PubMed Google Scholar
• Hanna, J. et al. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency. Cell 133, 250–264 (2008).
  CAS PubMed PubMed Central Google Scholar
• Aoi, T. et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321, 699–702 (2008).
  ADS CAS PubMed Google Scholar
• Utikal, J., Maherali, N., Kulalert, W. & Hochedlinger, K. Sox2 is dispensable for the reprogramming of melanocytes and melanoma cells into induced pluripotent stem cells. J. Cell Sci. 122, 3502–3510 (2009).
  CAS PubMed PubMed Central Google Scholar
• Sun, N. et al. Feeder-free derivation of induced pluripotent stem cells from adult human adipose stem cells. Proc. Natl Acad. Sci. USA 106, 15720–15725 (2009).
  ADS CAS PubMed PubMed Central Google Scholar
• Maherali, N. et al. A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell 3, 340–345 (2008).
  CAS PubMed PubMed Central Google Scholar
• Tesar, P. J. et al. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 448, 196–199 (2007).
  ADS CAS PubMed Google Scholar
• Wray, J., Kalkan, T. & Smith, A. G. The ground state of pluripotency. Biochem. Soc. Trans. 38, 1027–1032 (2010).
  CAS PubMed Google Scholar
• Hanna, J. H., Saha, K. & Jaenisch, R. Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 143, 508–525 (2010).
  CAS PubMed PubMed Central Google Scholar
• Maherali, N. & Hochedlinger, K. Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell 3, 595–605 (2008).
  CAS PubMed Google Scholar
• Stadtfeld, M., Maherali, N., Breault, D. T. & Hochedlinger, K. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell 2, 230–240 (2008). This study enumerated the molecular markers and functional criteria for defining reprogrammed cell populations.
  CAS PubMed PubMed Central Google Scholar
• Chan, E. M. et al. Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells. Nature Biotechnol. 27, 1033–1037 (2009).
  CAS Google Scholar
• Payer, B., Lee, J. T. & Namekawa, S. H. X-inactivation and X-reactivation: epigenetic hallmarks of mammalian reproduction and pluripotent stem cells. Hum. Genet. 130, 265–280 (2011).
  PubMed PubMed Central Google Scholar
• Maherali, N. et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1, 55–70 (2007).
  CAS PubMed Google Scholar
• Stadtfeld, M. et al. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature 465, 175–181 (2010).
  ADS CAS PubMed PubMed Central Google Scholar
• Boland, M. J. et al. Adult mice generated from induced pluripotent stem cells. Nature 461, 91–94 (2009).
  ADS CAS PubMed Google Scholar
• Zhao, X. Y. et al. iPS cells produce viable mice through tetraploid complementation. Nature 461, 86–90 (2009).
  ADS CAS PubMed Google Scholar
• Eakin, G. S., Hadjantonakis, A. K., Papaioannou, V. E. & Behringer, R. R. Developmental potential and behavior of tetraploid cells in the mouse embryo. Dev. Biol. 288, 150–159 (2005).
  CAS PubMed Google Scholar
• Eggan, K. & Jaenisch, R. Differentiation of F1 embryonic stem cells into viable male and female mice by tetraploid embryo complementation. Methods Enzymol. 365, 25–39 (2003).
  PubMed Google Scholar
• Lensch, M. W., Schlaeger, T. M., Zon, L. I. & Daley, G. Q. Teratoma formation assays with human embryonic stem cells: a rationale for one type of human-animal chimera. Cell Stem Cell 1, 253–258 (2007).
  CAS PubMed Google Scholar
• Park, I. H. et al. Disease-specific induced pluripotent stem cells. Cell 134, 877–886 (2008). This study derived iPS cells from patients with a range of diseases, demonstrating the applications of iPS cells for disease modelling, pathogenesis studies and drug development.
  CAS PubMed PubMed Central Google Scholar
• Daley, G. Q. et al. Broader implications of defining standards for the pluripotency of iPSCs. Cell Stem Cell 4, 200–202 (2009).
  CAS PubMed Google Scholar
• Miura, K. et al. Variation in the safety of induced pluripotent stem cell lines. Nature Biotechnol. 27, 743–745 (2009).
  CAS Google Scholar
• Feng, Q. et al. Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence. Stem Cells 28, 704–712 (2010).
  PubMed Google Scholar
• Hu, B. Y. et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc. Natl Acad. Sci. USA 107, 4335–4340 (2010).
  ADS CAS PubMed PubMed Central Google Scholar
• Kim, K. et al. Epigenetic memory in induced pluripotent stem cells. Nature 467, 285–290 (2010). This report describes an exhaustive comparison of pluripotent stem cells derived from mouse embryos or reprogrammed through nuclear transfer or transcription factor co-expression, by using several in vitro differentiation assays and methylation analysis; it revealed that iPS cells manifest molecular and behavioural features of the donor tissue of origin, indicating a 'memory' of the somatic tissue.
  ADS CAS PubMed PubMed Central Google Scholar
• Hu, Q., Friedrich, A. M., Johnson, L. V. & Clegg, D. O. Memory in induced pluripotent stem cells: reprogrammed human retinal-pigmented epithelial cells show tendency for spontaneous redifferentiation. Stem Cells 28, 1981–1991 (2010).
  CAS PubMed Google Scholar
• Bar-Nur, O., Russ, H. A., Efrat, S. & Benvenisty, N. Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet Beta cells. Cell Stem Cell 9, 17–23 (2011).
  CAS PubMed Google Scholar
• Urbach, A., Bar-Nur, O., Daley, G. Q. & Benvenisty, N. Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell 6, 407–411 (2010).
  CAS PubMed PubMed Central Google Scholar
• Bock, C. et al. Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 144, 439–452 (2011). This study generated genome-wide reference maps of DNA methylation and gene expression, together with the differentiation potential of each cell line, providing a resource for assessing the similarity of ES cells and iPS cells, as well as for predicting the differentiation efficiency of a particular cell line and creating a scorecard for the comprehensive characterization of any pluripotent cell line.
  CAS PubMed PubMed Central Google Scholar
• Pick, M. et al. Clone- and gene-specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells 27, 2686–2690 (2009).
  CAS PubMed Google Scholar
• Ben-David, U., Mayshar, Y. & Benvenisty, N. Large-scale analysis reveals acquisition of lineage-specific chromosomal aberrations in human adult stem cells. Cell Stem Cell 9, 97–102 (2011).
  CAS PubMed Google Scholar
• Hussein, S. M. et al. Copy number variation and selection during reprogramming to pluripotency. Nature 471, 58–62 (2011). This study showed that significantly more CNVs were present in early-passage human iPS cells than in intermediate-passage human iPS cells, fibroblasts or human ES cells; it also provided evidence that CNVs conferred a selective disadvantage.
  ADS CAS PubMed Google Scholar
• Laurent, L. C. et al. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Cell Stem Cell 8, 106–118 (2011).
  CAS PubMed PubMed Central Google Scholar
• Ghosh, Z. et al. Persistent donor cell gene expression among human induced pluripotent stem cells contributes to differences with human embryonic stem cells. PLoS ONE 5, e8975 (2010).
  ADS PubMed PubMed Central Google Scholar
• Wernig, M. et al. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nature Biotechnol. 26, 916–924 (2008).
  CAS Google Scholar
• Mikkelsen, T. S. et al. Dissecting direct reprogramming through integrative genomic analysis. Nature 454, 49–55 (2008).
  ADS CAS PubMed PubMed Central Google Scholar
• Lister, R. et al. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Nature 471, 68–73 (2011). This study analysed the methylomes of human iPS cells, ES cells, somatic cells, and differentiated iPS and ES cells, and revealed megabase-scale DMRs in iPS cells, indicating incomplete reprogramming of these cells.
  ADS CAS PubMed PubMed Central Google Scholar
• Shen, Y. et al. X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations. Proc. Natl Acad. Sci. USA 105, 4709–4714 (2008).
  ADS CAS PubMed PubMed Central Google Scholar
• Tchieu, J. et al. Female human iPSCs retain an inactive X chromosome. Cell Stem Cell 7, 329–342 (2010).
  CAS PubMed PubMed Central Google Scholar
• Marchetto, M. C. et al. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 143, 527–539 (2010).
  CAS PubMed PubMed Central Google Scholar
• Pomp, O. et al. Unexpected X chromosome skewing during culture and reprogramming of human somatic cells can be alleviated by exogenous telomerase. Cell Stem Cell 9, 156–165 (2011).
  CAS PubMed Google Scholar
• Bernstein, B. E. et al. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125, 315–326 (2006).
  CAS PubMed Google Scholar
• Newman, A. M. & Cooper, J. B. Lab-specific gene expression signatures in pluripotent stem cells. Cell Stem Cell 7, 258–262 (2010).
  CAS PubMed Google Scholar
• Humpherys, D. et al. Epigenetic instability in ES cells and cloned mice. Science 293, 95–97 (2001).
  CAS PubMed Google Scholar
• Soldner, F. et al. Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors. Cell 136, 964–977 (2009).
  CAS PubMed PubMed Central Google Scholar
• Carey, B. W. et al. Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells. Cell Stem Cell 9, 588–598 (2011).
  CAS PubMed Google Scholar
• Ohi, Y. et al. Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nature Cell Biol. 13, 541–549 (2011).
  CAS PubMed Google Scholar
• Polo, J. M. et al. Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nature Biotechnol. 28, 848–855 (2010).
  CAS Google Scholar
• Martinez, Y. et al. Cellular diversity within embryonic stem cells: pluripotent clonal sublines show distinct differentiation potential. J. Cell. Mol. Med. http://dx.doi.org/10.1111/j.1582-4934.2011.01334.x (in the press).
• Osafune, K. et al. Marked differences in differentiation propensity among human embryonic stem cell lines. Nature Biotechnol. 26, 313–315 (2008).
  CAS Google Scholar
• Muller, F. J. et al. A bioinformatic assay for pluripotency in human cells. Nature Methods 8, 315–317 (2011).
  PubMed PubMed Central Google Scholar
• Lee, G. et al. Modelling pathogenesis and treatment of familial dysautonomia using patient-specific iPSCs. Nature 461, 402–406 (2009).
  ADS CAS PubMed PubMed Central Google Scholar
• Moretti, A. et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. 363, 1397–1409 (2010).
  CAS PubMed Google Scholar
• Itzhaki, I. et al. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 471, 225–229 (2011). This study generated iPS cells from patients with long QT syndrome and stimulated them to differentiate into cardiomyocytes that paralleled the disease phenotype in vitro , and these cells were then used to evaluate the potency of existing and new therapeutic agents.
  ADS CAS PubMed Google Scholar
• Agarwal, S. et al. Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients. Nature 464, 292–296 (2010).
  ADS CAS PubMed PubMed Central Google Scholar
• Batista, L. F. et al. Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells. Nature 474, 399–402 (2011).
  CAS PubMed PubMed Central Google Scholar
• Agarwal, S. & Daley, G. Q. Telomere dynamics in dyskeratosis congenita: the long and the short of iPS. Cell Res. 21, 1157–1160 (2011).
  CAS PubMed PubMed Central Google Scholar
• Hanna, J. et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318, 1920–1923 (2007).
  ADS CAS PubMed Google Scholar
• Wernig, M. et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl Acad. Sci. USA 105, 5856–5861 (2008).
  ADS CAS PubMed PubMed Central Google Scholar
• Zhao, T., Zhang, Z. N., Rong, Z. & Xu, Y. Immunogenicity of induced pluripotent stem cells. Nature 474, 212–215 (2011).
  CAS PubMed Google Scholar
• Harrison, N. J., Baker, D. & Andrews, P. W. Culture adaptation of embryonic stem cells echoes germ cell malignancy. Int. J. Androl. 30, 275–281 (2007).
  PubMed Google Scholar
• Mayshar, Y. et al. Identification and classification of chromosomal aberrations in human induced pluripotent stem cells. Cell Stem Cell 7, 521–531 (2010).
  CAS PubMed Google Scholar
• Murry, C. E. & Keller, G. Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development. Cell 132, 661–680 (2008).
  CAS PubMed Google Scholar
• Lowry, W. E. et al. Generation of human induced pluripotent stem cells from dermal fibroblasts. Proc. Natl Acad. Sci. USA 105, 2883–2888 (2008).
  ADS CAS PubMed PubMed Central Google Scholar
• Huangfu, D. et al. Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2. Nature Biotechnol. 26, 1269–1275 (2008).
  CAS Google Scholar
• Sommer, C. A. et al. Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells 27, 543–549 (2009).
  CAS PubMed PubMed Central Google Scholar
• Anokye-Danso, F. et al. Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency. Cell Stem Cell 8, 376–388 (2011).
  CAS PubMed PubMed Central Google Scholar
• Woltjen, K. et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 458, 766–770 (2009).
  ADS CAS PubMed PubMed Central Google Scholar
• Somers, A. et al. Generation of transgene-free lung disease-specific human induced pluripotent stem cells using a single excisable lentiviral stem cell cassette. Stem Cells 28, 1728–1740 (2010).
  CAS PubMed PubMed Central Google Scholar
• Zhou, W. & Freed, C. R. Adenoviral gene delivery can reprogram human fibroblasts to induced pluripotent stem cells. Stem Cells 27, 2667–2674 (2009).
  CAS PubMed Google Scholar
• Stadtfeld, M., Nagaya, M., Utikal, J., Weir, G. & Hochedlinger, K. Induced pluripotent stem cells generated without viral integration. Science 322, 945–949 (2008).
  ADS CAS PubMed PubMed Central Google Scholar
• Okita, K., Nakagawa, M., Hyenjong, H., Ichisaka, T. & Yamanaka, S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 322, 949–953 (2008).
  ADS CAS PubMed Google Scholar
• Si-Tayeb, K. et al. Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors. BMC Dev. Biol. 10, 81 (2010).
  PubMed PubMed Central Google Scholar
• Fusaki, N., Ban, H., Nishiyama, A., Saeki, K. & Hasegawa, M. Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome. Proc. Jpn Acad. 85, 348–362 (2009).
  CAS Google Scholar
• Kim, D. et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4, 472–476 (2009).
  CAS PubMed PubMed Central Google Scholar
• Zhou, H. et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4, 381–384 (2009).
  CAS PubMed Google Scholar
• Warren, L. et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618–630 (2010).
  CAS PubMed PubMed Central Google Scholar
• Miyoshi, N. et al. Reprogramming of mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 8, 633–638 (2011).
  CAS PubMed Google Scholar
• Hanna, J. et al. Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc. Natl Acad. Sci. USA 107, 9222–9227 (2010).
  ADS CAS PubMed PubMed Central Google Scholar
• Buecker, C. et al. A murine ESC-like state facilitates transgenesis and homologous recombination in human pluripotent stem cells. Cell Stem Cell 6, 535–546 (2010).
  CAS PubMed PubMed Central Google Scholar
• Li, W. et al. Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 4, 16–19 (2009).
  PubMed Google Scholar
• Nichols, J. & Smith, A. Naive and primed pluripotent states. Cell Stem Cell 4, 487–492 (2009).
  CAS PubMed Google Scholar